Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | GLS | O94925 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | KLK7 | P49862 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22355969 | 1.00 | KMT2A (0.61) | KMT2AGLSALDH1A1GAAMEN1 | |
| SCHEMBL28061306 | 0.83 | MMP8 (0.50) | KMT2AGLSALDH1A1GAAMEN1 | |
| SCHEMBL13848573 | 0.81 | KMT2A (0.64) | KMT2AALDH1A1GAALMNAL3MBTL1 | |
| SCHEMBL3036253 | 0.81 | CYP2D6 (0.52) | KMT2AGLSALDH1A1LMNACYP3A4 | |
| Benzene SCHEMBL28174562 | 0.81 | CYP2D6 (0.52) | KMT2AGLSALDH1A1LMNACYP3A4 | |
| SCHEMBL3255039 | 0.81 | KMT2A (0.64) | KMT2AALDH1A1GAALMNAL3MBTL1 | |
| SCHEMBL18220934 | 0.81 | CYP2D6 (0.52) | KMT2AGLSALDH1A1LMNACYP3A4 | |
| SCHEMBL3255043 | 0.81 | KMT2A (0.64) | KMT2AALDH1A1GAALMNAL3MBTL1 | |
| SCHEMBL3036250 | 0.81 | CYP2D6 (0.52) | KMT2AGLSALDH1A1LMNACYP3A4 | |
| SCHEMBL28174560 | 0.81 | L3MBTL1 (0.50) | KMT2AGLSALDH1A1GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624309-B2 | Enol ether properfume | FIRMENICH SA (CH) | 2026-05-12 | — | — | US | disclosed |
| EP-4139274-B1 | ENOL ETHER PROPERFUME | FIRMENICH & CIE (CH) | 2024-02-14 | — | — | EP | disclosed |
| US-20230220298-A1 | ENOL ETHER PROPERFUME | FIRMENICH & CIE (CH) | 2023-07-13 | — | — | US | disclosed |
| EP-4139274-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2023-03-01 | — | — | EP | disclosed |
| CN-115702138-A | Enol ether pro-fragrances | 弗门尼舍有限公司 | 2023-02-14 | — | — | CN | disclosed |
| WO-2021250164-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2021-12-16 | — | — | WO | disclosed |
| US-RE45128-E1 | Cephalotaxane derivatives and their processes of preparation and purification | IVAX International GmbH (CH) | 2014-09-09 | — | — | US | disclosed |
| CN-1183829-C | Insecticide compositions made from polymers | BAYER AG (DE) | 2005-01-12 | — | — | CN | disclosed |
| CN-1211162-A | Insecticide compositions made from polymers | BAYER AG (DE) | 1999-03-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220298-A1 | ENOL ETHER PROPERFUME | CYP2E1, ADH5, ECI1 | KMT2A 4234/4885GLS 2208/4885ALDH1A1 107/4885 |
| US-12624309-B2 | Enol ether properfume | CYP2E1, CBR1, ADH5 | KMT2A 4508/4885GLS 2416/4885ALDH1A1 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.